Chiltern Opens New Office in Argentina
Chiltern International Limited (Chiltern), a global clinical contract research organization (CRO) announced that it has opened a new office in Argentina.
Oscar Podesta, Chiltern Executive Director, Latin America, leads this endeavor.“Our office, strategically located in suburban Pilar, is a natural next step to our development in Argentina. The office’s state-of-the-art facilities and technology are designed to support our growing client needs in Mexico, Chile, Peru and throughout all Latin America, complementing Chiltern’s Sao Paulo, Brazil office,” commented Oscar.
“Chiltern’s opening of the Buenos Aires office in 2010 continues our globalization effort following the opening of four new offices in 2009,” stated Glenn Kerkhof, Chiltern CEO. “Chiltern’s strong presence in Argentina, Brazil, Mexico and the entire Latin American region demonstrates our commitment to providing high quality services globally.”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
